People with a significant deficiency
AMs from PLWH also show a pro-inflammatory phenotype, higher TNF production, and impaired phagocytic ability, which in turn leads to poor pathogen clearance (57, 9799)
In vitro experiments confirmed that A 25-35 treatment significantly inhibited the activation of the NRF2/SLC7A11/GPX4 signaling pathway in HT22 cells, upregulated the expression of Fe 2+ , TFR1, ACSL4, MDA, and GSSG, and decreased the expression of FTH1, SOD, and GSH, as well as the GSH/GSSG ratio, resulting in dysregulated neuronal iron metabolism, impaired amino acid antioxidant systems, mitochondrial dysfunction, and ferroptosis, which ultimately promoted neuronal injury
The 8mg dose achieved 81.4% reduction